Fucidin 1.5 g/100 cm2 Norvēģija - norvēģu - Statens legemiddelverk

fucidin 1.5 g/100 cm2

leo pharma - fusidinsyre - impregnert kompress - 1.5 g/100 cm2

Fucidin 250 mg Norvēģija - norvēģu - Statens legemiddelverk

fucidin 250 mg

leo pharma - fusidinsyre - tablett, filmdrasjert - 250 mg

Fucidin-Hydrocortison 20 mg/ g / 10 mg/ g Norvēģija - norvēģu - Statens legemiddelverk

fucidin-hydrocortison 20 mg/ g / 10 mg/ g

leo pharma - fusidinsyrehemihydrat / hydrokortisonacetat - krem - 20 mg/ g / 10 mg/ g

Finacea 15 % Norvēģija - norvēģu - Statens legemiddelverk

finacea 15 %

leo pharma a/s (danmark) - azelainsyre - gel - 15 %

Kaleorid 750 mg Norvēģija - norvēģu - Statens legemiddelverk

kaleorid 750 mg

leo pharma - kaliumklorid - depottablett - 750 mg

Skinoren 20 % Norvēģija - norvēģu - Statens legemiddelverk

skinoren 20 %

leo pharma a/s (danmark) - azelainsyre - krem - 20 %

Lamivudine/Zidovudine Teva Eiropas Savienība - norvēģu - EMA (European Medicines Agency)

lamivudine/zidovudine teva

teva pharma b.v.  - lamivudine, zidovudine - hiv-infeksjoner - antivirale midler til systemisk bruk - lamivudin / zidovudin teva er angitt i antiretroviral kombinationsbehandling for behandling av hiv-infeksjon (human immunodeficiency virus).

Picato Eiropas Savienība - norvēģu - EMA (European Medicines Agency)

picato

leo laboratories ltd. - ingenol mebutate - keratose, actinic - antibiotika og chemotherapeutics for dermatologisk bruk, andre chemotherapeutics - picato er indikert for kutan behandling av ikke‑hyperkeratotic, ikke‑hypertrofisk aktinisk keratose i voksne.

Protopic Eiropas Savienība - norvēģu - EMA (European Medicines Agency)

protopic

leo pharma a/s - takrolimus - dermatitt, atopisk - andre dermatologiske preparater - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. forekommer fire ganger eller mer per år) som har hatt et første svar til maksimalt seks uker behandling av to ganger daglig takrolimus salve (lesjoner ryddet, nesten ryddet eller mildt rammet).